Where would I be if I had not met these amazing colleagues, collaborators, & friends when I moved to Memorial Sloan Kettering Cancer Center in 2019? [I shudder to think]

Even though we now all work at different institutions, our collaborations continue.

And the friendship? That is forever. 💕

While often unreported, cancer-related fatigue impacts the quality of life of up to 80-100% of patients, estimates @americancancer.

Learn about the importance of addressing fatigue in #cancersurvivorship with our Marleen Meyers and Bhavana Pothuri: bit.ly/3xEyBgo

Radiation oncologist and administrative leader Dr. Oren Cahlon is helping shape the future of world-class cancer care.

Learn about his initiatives to expand services to our patients at NYU Langone Hospital—Long Island NYU Langone in Brooklyn: bit.ly/3VLkksv

A recently launched phase 3 clinical trial is evaluating the efficacy of experimental mRNA vaccine v940 combined with pembrolizumab in the treatment of metastatic #melanoma .

Learn more from lead investigator Dr. Jeffrey Weber: bit.ly/49hyhla

Dr. Kari Hacker presents on importance of HER2 testing in #endometrialcancer - ⁦trastuzumab deruxtecan NCCN listed and available as tx option SGO⁩ ⁦The GOG Foundation Inc.⁩ ⁦ACOG⁩ ⁦IGCS⁩ ⁦NRG Oncology⁩ ⁦FdtnForWomensCancer⁩ ⁦GYN Cancer | #GYNCSM⁩

Dr. Bridgette Thom, PhD presenting on our #priorauthorization in #cancer work APOS. Missed you, Fumiko Ladd Chino, MD! #APOS2024 Memorial Sloan Kettering Cancer Center UNC Lineberger URochester School of Nursing

Clear #congestionpricing exemptions are needed for patients w cancer on active treatment or others with chronic, serious illness who need medical care and for whom public transit is not a safe option. Immunocompromised people need protections but may not qualify for disability.🙏

“Patient outcomes are far worse without health insurance... It doesn't matter what political party you are affiliated with — you can care that patients have access to medical treatment.'

Read why Dr Haley Moss is my #SHERO : healio.com/news/hematolog…

Sometimes you google yourself and find yourself in literally the BEST group of people. WOW.

#DreamTeam 🤩💫🏆

Program chair of @SGO_Org’s 2024 Annual Meeting on Women’s Cancer is our #GYNCSM expert Dr. Bhavana Pothuri (@BPothuri)! Also, during #SGO2024 , our #gynOnc Emeline Aviki, MD, MBA will become a member of the group's board of directors! 

Learn more | Register: registration.experientevent.com/ShowSGO241

Reduced healthcare access contributes to delay of care in endometrial cancer 🚨 SGO IGCS ESGO ASCO ESMO - Eur. Oncology OncoAlert sciencedirect.com/science/articl…

💊💸Dr Meera Ragavan, MD MPH leads this JCO Oncology Practice review of pharmacy assistance programs for oral anticancer drugs.
She highlights that multilevel solutions are needed to curb costs for pts & ensure affordable, equitable cancer care delivery.
🚨OncoAlert: ascopubs.org/doi/full/10.12…

Adding a neoantigen mRNA vaccine to pembrolizumab improves survival outcomes in resected high-risk #melanoma , the KEYNOTE-942 trial suggests

In an interview with OncLive.com, our study author Dr. Jeffrey Weber expands on the latest data presented at #ESMO23 : bit.ly/42ccQA6

No greater joy than watching your mentee succeed. Kristen Spencer is a leader on fire, running a phase 1 unit with dramatic accrual increases and timelines of 40-60 days to activation. I watched what went into this trial behnd the scenes and super excited to offer it Perlmutter Cancer Center at NYU Langone Health.

A specialist in the field of #CardioOnc , our Dr. Michelle Bloom (@DrMishBloom) will join NYU Langone Hospital—Long Island's Aaron E. Katz, MD this Sunday, 1/14, to discuss #hearthealth management in cancer care.

Tune in live at 7 am on WOR 710AM, or listen here: ihr.fm/3ENmtu2

Congrats! This is a well deserved honor for Eric Rios-Doria, MD! Dr. Doria has been killing it as a #GynOnc fellow. Not only is he the fellow in training SGO board representative, he’s one of the @GynOncJnls social media fellows!
Keep killing it! #GynCSM

Proud to say I knew Dr Emeline Aviki, MD, MBA when... but let's be honest, she is a BORN LEADER destined for greatness. I was lucky to meet her 9/2019 the same month I started as faculty at MSK.

We have been collaborating ever since; honored to have her as a peer mentor & friend. 🤩

Congratulations to Emeline Aviki, MD, MBA, of Perlmutter Cancer Center at NYU Langone Hospital—Long Island, who will serve on the 2024-2025 board of directors for The Society of Gynecologic Oncology (@SGO_Org)! #gyncsm

Learn about the SGO’s vision: bit.ly/41TuIiJ

Congrats to NY OB Society member Emeline Aviki, MD, MBA 👇🏽👇🏽👇🏽

In a podcast from AJMC, PC3I Director Justin Bekelman sat down with Emeline Aviki, MD, MBA & Stephen Schleicher to discuss collaboration between academic medicine & community #oncology , & testing innovative #cancercare delivery in these settings.
ajmc.com/view/oncology-…